Bradley W. Caprathe

Publications by Year

Research Areas

Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Chemical Reaction Mechanisms, Synthesis and pharmacology of benzodiazepine derivatives, Adenosine and Purinergic Signaling

Most-Cited Works

• → 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties(1990)254 cited
• → 2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease(1998)157 cited
• → Amnesia-reversal activity of a series of cyclic imides(1987)66 cited
• → The design and synthesis of sulfonamides as caspase-1 inhibitors(2003)57 cited
• → The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors(2008)45 cited
• → Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine(1991)43 cited
• → Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors(1996)40 cited
• → Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors(1993)30 cited
• → PD-90780, a Nonpeptide Inhibitor of Nerve Growth Factor′s Binding to the P75 NGF Receptor(1995)30 cited
• → Design and Synthesis of m1-Selective Muscarinic Agonists: (R)-(−)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI-1017), a Functionally m1-Selective Muscarinic Agonist(1998)29 cited